Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2024
A randomized controlled trial of postbiotic administration during antibiotic treatment increases microbiome diversity and enriches health associated taxa
Jonas Schluter, Fanny Matheis, Wataru Ebina, et al.
Gynecologic Oncology Reports
|
September 2, 2025
Exploratory evaluation of immunotherapy response and medication use in endometrial and cervical carcinoma
Julia Chalif, Molly Morton, Eric McLaughlin, et al.
Infection and Immunity
|
November 28, 2025
A retrospectively registered pilot randomized controlled trial of postbiotic administration during antibiotic treatment increases microbiome diversity and enriches health-associated taxa
Jonas Schluter, William Jogia, Fanny Matheis, et al.
Bioorganic & Medicinal Chemistry
|
June 14, 2006
Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffold
Eddy W Yue, Brian Wayland, Brent Douty, et al.
Gynecologic Oncology
|
June 27, 2026
PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy
Laura M Chambers, Daniel Spakowicz, Julia Chalif, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2018
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy
Carmela Passaro, Quazim Alayo, Isabella De Laura, et al.
Vaccines
|
June 2, 2021
Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease
Elshafa Hassan Ahmed, Eric Brooks, Shelby Sloan, et al.
Journal of Cancer Survivorship : Research and Practice
|
September 5, 2023
Changes in physical function in older women with endometrial cancer with or without adjuvant therapy
Allison M Quick, Eric McLaughlin, Jessica L Krok Schoen, et al.
Frontiers in Oncology
|
May 16, 2022
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias
Zachary Braunstein, Eric McLaughlin, Miguel Ruiz, et al.
Cancers
|
March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma
Walter Hanel, Polina Shindiapina, David A Bond, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2024
A randomized controlled trial of postbiotic administration during antibiotic treatment increases microbiome diversity and enriches health associated taxa
Jonas Schluter, Fanny Matheis, Wataru Ebina, et al.
Gynecologic Oncology Reports
|
September 2, 2025
Exploratory evaluation of immunotherapy response and medication use in endometrial and cervical carcinoma
Julia Chalif, Molly Morton, Eric McLaughlin, et al.
Infection and Immunity
|
November 28, 2025
A retrospectively registered pilot randomized controlled trial of postbiotic administration during antibiotic treatment increases microbiome diversity and enriches health-associated taxa
Jonas Schluter, William Jogia, Fanny Matheis, et al.
Bioorganic & Medicinal Chemistry
|
June 14, 2006
Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffold
Eddy W Yue, Brian Wayland, Brent Douty, et al.
Gynecologic Oncology
|
June 27, 2026
PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy
Laura M Chambers, Daniel Spakowicz, Julia Chalif, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2018
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy
Carmela Passaro, Quazim Alayo, Isabella De Laura, et al.
Vaccines
|
June 2, 2021
Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease
Elshafa Hassan Ahmed, Eric Brooks, Shelby Sloan, et al.
Journal of Cancer Survivorship : Research and Practice
|
September 5, 2023
Changes in physical function in older women with endometrial cancer with or without adjuvant therapy
Allison M Quick, Eric McLaughlin, Jessica L Krok Schoen, et al.
Frontiers in Oncology
|
May 16, 2022
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias
Zachary Braunstein, Eric McLaughlin, Miguel Ruiz, et al.
Cancers
|
March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma
Walter Hanel, Polina Shindiapina, David A Bond, et al.
Page
of 5